The company’s cross-disciplinary team lead by a Triple-Dr, Berenika Maciejewicz, applies bioengineering and AI towards human lifespan and healthspan extension.
New research on the "Reward Positivity" brain signal distinguishes between rewards and goals, offering a new way to measure and treat depression.
A 20-year study reveals that "speed of processing" brain training can reduce the risk of dementia by 25% in older adults.
A new study has revealed the cognitive impact of menopause.
Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the ...
Substance use and substance use disorders are major challenges for brain health across the human lifespan. Despite extensive research, important gaps remain ...
FINDLAY, OH - January 21, 2026 - PRESSADVANTAGE - As work and daily life continue to accelerate, decision timelines are ...
Women in Integrative Neuroscience: Advances, Innovations, and Challenges from the Female Perspective
For decades, women have played a pivotal role in advancing neuroscience, yet their contributions often remain underrepresented in scientific discourse.
A global study reveals significant variations in neurological Long COVID symptoms, highlighting the need for tailored ...
Scientists still don’t know how the brain turns physical activity into thoughts, feelings, and awareness—but a powerful new tool may help crack the mystery. Researchers at MIT are exploring ...
AbbVie ABBV has built a substantial neuroscience franchise. While the segment was initially anchored by Botox Therapeutic and the depression drug Vraylar, its offerings now include the oral migraine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results